Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Hypertension and Cardiometabolic Risk Across the CKD Spectrum
  • Clinical
  • Bookmark Icon
  • Efficacy of Finerenone in Primary Cardiovascular Prevention: A Mechanistic Analysis Using the AHA PREVENT™ Risk Score
  • Schedule
    Notes
  • MDP0825
    Set Timezone
  •  
    View Map

Generic 'disconnected' Message
Ashish Verma, Dept of Med, Section of Nephrology, Boston Medical Ctr, and Boston Univ Chobanian & Avedisian Sch of Med, Boston, MA; Rajiv Agarwal, Indiana Univ Sch of Med and Richard L. Roudebush VA Medical Ctr, Indianapolis, IN; Stefan D Anker, Dept of Cardiology (CVK) of German Heart Ctr Charité; German Ctr for Cardiovascular Res (DZHK) partner site Berlin, Charité Univsmedizin, Berlin, Germany; Sophie E Claudel, Dept of Med, Section of Nephrology, Boston Medical Ctr, and Boston Univ Chobanian & Avedisian Sch of Med, Boston, MA; Bertram Pitt, Dept of Med, Univ of Michigan Sch of Med, Ann Arbor, MI; Peter Rossing, Steno Diabetes Ctr Copenhagen, Copenhagen, Denmark; Luis M Ruilope, Cardiorenal Translational Lab and Hypertension Unit, Inst of Res imas12, Madrid, Spain; Anand Vaidya, Div of Endocrinology, Diabetes, and Metabolism, Mass General Brigham and Harvard Medical Sch, Boston, MA; Sushrut Waikar, Insa M Schmidt, Dept of Med, Section of Nephrology, Boston Medical Ctr, and Boston Univ Chobanian & Avedisian Sch of Med, Boston, MA; Sonia Gomez, Syneos Health LLC (providing service to Bayer), Morrisville, NC; Margarida Seco, Global Medical Affairs Cardiorenal, Bayer Portugal SA, Lisbon, Portugal; Zihe Zheng, Medical Affairs Cardio-Renal Div, Bayer U.S. LLC, Whippany, NJ; Gerasimos Filippatos, Natl and Kapodistrian Univ of Athens, Sch of Med, Dept of Cardiology, Attikon Univ Hosp, Athens, Greece
Communities
Navigation
Session Type
Onsite Viewing
Main Session